×
About 10,080 results

ALLMedicine™ Myasthenia Gravis Center

Research & Reviews  4,811 results

Acute exudative paraneoplastic polymorphous vitelliform maculopathy in a patient with t...
https://doi.org/10.1177/1120672121994042
European Journal of Ophthalmology; Yu H, Ma X et. al.

Feb 23rd, 2021 - This is the first reported case of acute exudative paraneoplastic polymorphous vitelliform maculopathy (AEPPVM) in a patient with thymoma, accompanied by myasthenia gravis (MG) and polymyositis. To examine the pathogenesis of ocular disease in a p...

Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study.
https://doi.org/10.1159/000512973
Neuroepidemiology Sobieszczuk E, Napiórkowski Ł et. al.

Feb 21st, 2021 - Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction. MG epidemiology has not been studied in Poland in a nationwide study before. Our epidemiological data were drawn from the National Health Fund (Narodowy Fundusz Zd...

Developing outcome measures of disease activity in Pediatric Myasthenia.
https://doi.org/10.1002/mus.27208
Muscle & Nerve; Prior DE, Cooper BA et. al.

Feb 19th, 2021 - Pediatric myasthenia encompasses juvenile myasthenia gravis (JMG) and congenital myasthenic syndrome (CMS) which are chronic disorders with fluctuating symptoms amenable to medical therapy. Disease activity and treatment response may be difficult ...

Transient neonatal myasthenia gravis: refining risk estimate for infants born to women ...
https://doi.org/10.1038/s41372-021-00970-6 10.1542/neo.11-4-e200 10.1186/1471-2474-5-42 10.4414/sanp.2007.01882 10.1016/j.nmd.2017.01.021 10.3109/15513815.2016.1164773 10.1212/01.wnl.0000307751.20968.f1 10.1136/jnnp-2013-305572 10.1016/j.jbi.2015.05.003 10.1002/mus.25095 10.1055/s-0036-1579624 10.1016/j.nmd.2017.03.012 10.1097/CND.0b013e3181a78280 10.1016/j.nmd.2008.03.006
Journal of Perinatology : Official Journal of the Califor... Kochhar PK, Schumacher RE et. al.

Feb 18th, 2021 - Transient neonatal myasthenia gravis (TNMG) can render a neonate vulnerable to catastrophic respiratory depression. Our aim was to describe the clinical manifestations of TNMG, and to determine when the myasthenic signs become apparent in TNMG. We...

Myasthenia Symptom Burden, Fatigue, and Sleep: Are They Related?
https://doi.org/10.1097/CND.0000000000000321
Journal of Clinical Neuromuscular Disease; Yang S, Miglis MG et. al.

Feb 17th, 2021 - Our aim is to explore the relationship between myasthenia gravis (MG)-related symptom burden, sleep quality, and fatigue in a diverse group of self-identified MG patients. Patients provided relevant myasthenia disease data and completed the MG QOL...

see more →

Guidelines  13 results

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic synd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105910
Journal of the Neurological Sciences; , Jacob S et. al.

Apr 4th, 2020 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.|2020| ,Jacob S,Muppidi S,Guidon A,Guptill J,|complications,drug therapy,epidemiology,therapeutic use,therapeutic use,t...

The Association of British Neurologists' myasthenia gravis guidelines.
https://doi.org/10.1111/nyas.13503
Annals of the New York Academy of Sciences; Sussman J, Farrugia ME et. al.

Nov 9th, 2017 - Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction for which many therapies were developed before the era of evidence-based medicine. Despite the basic principles of treatment being well known, patients continue to recei...

International consensus guidance for management of myasthenia gravis: Executive summary.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977114
Neurology Sanders DB, Wolfe GI et. al.

Jun 30th, 2016 - To develop formal consensus-based guidance for the management of myasthenia gravis (MG). In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international expe...

Guidelines for treatment of autoimmune neuromuscular transmission disorders.
https://doi.org/10.1111/j.1468-1331.2010.03019.x
European Journal of Neurology; Skeie GO, Apostolski S et. al.

Apr 20th, 2010 - Important progress has been made in our understanding of the autoimmune neuromuscular transmission (NMT) disorders; myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS) and neuromyotonia (Isaacs' syndrome). To prepare consensus guideli...

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological ...
https://doi.org/10.1111/j.1468-1331.2008.02246.x
European Journal of Neurology; Elovaara I, Apostolski S et. al.

Sep 17th, 2008 - Despite high-dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune-mediated neurological diseases, the consensus on its optimal use is insufficient. To define the evidence-based optimal use of IVIG in neurology, ...

see more →

Drugs  55 results see all →

Clinicaltrials.gov  4,999 results

Acute exudative paraneoplastic polymorphous vitelliform maculopathy in a patient with t...
https://doi.org/10.1177/1120672121994042
European Journal of Ophthalmology; Yu H, Ma X et. al.

Feb 23rd, 2021 - This is the first reported case of acute exudative paraneoplastic polymorphous vitelliform maculopathy (AEPPVM) in a patient with thymoma, accompanied by myasthenia gravis (MG) and polymyositis. To examine the pathogenesis of ocular disease in a p...

Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study.
https://doi.org/10.1159/000512973
Neuroepidemiology Sobieszczuk E, Napiórkowski Ł et. al.

Feb 21st, 2021 - Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction. MG epidemiology has not been studied in Poland in a nationwide study before. Our epidemiological data were drawn from the National Health Fund (Narodowy Fundusz Zd...

Developing outcome measures of disease activity in Pediatric Myasthenia.
https://doi.org/10.1002/mus.27208
Muscle & Nerve; Prior DE, Cooper BA et. al.

Feb 19th, 2021 - Pediatric myasthenia encompasses juvenile myasthenia gravis (JMG) and congenital myasthenic syndrome (CMS) which are chronic disorders with fluctuating symptoms amenable to medical therapy. Disease activity and treatment response may be difficult ...

Transient neonatal myasthenia gravis: refining risk estimate for infants born to women ...
https://doi.org/10.1038/s41372-021-00970-6 10.1542/neo.11-4-e200 10.1186/1471-2474-5-42 10.4414/sanp.2007.01882 10.1016/j.nmd.2017.01.021 10.3109/15513815.2016.1164773 10.1212/01.wnl.0000307751.20968.f1 10.1136/jnnp-2013-305572 10.1016/j.jbi.2015.05.003 10.1002/mus.25095 10.1055/s-0036-1579624 10.1016/j.nmd.2017.03.012 10.1097/CND.0b013e3181a78280 10.1016/j.nmd.2008.03.006
Journal of Perinatology : Official Journal of the Califor... Kochhar PK, Schumacher RE et. al.

Feb 18th, 2021 - Transient neonatal myasthenia gravis (TNMG) can render a neonate vulnerable to catastrophic respiratory depression. Our aim was to describe the clinical manifestations of TNMG, and to determine when the myasthenic signs become apparent in TNMG. We...

see more →

News  181 results

New Steroid Dosing Regimen for Myasthenia Gravis
https://www.medscape.com/viewarticle/945898

Feb 15th, 2021 - The findings of a new randomized trial support the rapid tapering of prednisone in patients with generalized myasthenia gravis requiring combined corticosteroid and azathioprine therapy. The trial showed that the conventional slow tapering regimen...

Ocular Side Effects Possible With Checkpoint Inhibitors
https://www.medscape.com/viewarticle/941652

Nov 26th, 2020 - NEW YORK (Reuters Health) - People who use immune-checkpoint inhibitors have an increased risk of noninfectious uveitis and myasthenia gravis, according to a database study. Several case series have reported ocular side effects of checkpoint inhib...

COVID-19 Linked to Development of Myasthenia Gravis
https://www.staging.medscape.com/viewarticle/935985

Aug 18th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Myasthenia gravis should be added to the growing list of potential neurological sequelae associated with COVID-19, new research suggests. Clinicia...

COVID-19 Linked to Development of Myasthenia Gravis
https://www.medscape.com/viewarticle/935985

Aug 18th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Myasthenia gravis should be added to the growing list of potential neurological sequelae associated with COVID-19, new research suggests. Clinicia...

Rituximab Promising in New-Onset Myasthenia Gravis
https://www.staging.medscape.com/viewarticle/930271

May 10th, 2020 - Patients with myasthenia gravis (MG) who are treated early with the monoclonal antibody rituximab (multiple brands) achieve remission sooner than those treated later in the disease process, new research suggests. Investigators compared patients wi...

see more →

Patient Education  21 results see all →